Navigation Links
Researchers Present Key Findings Comparing PEM to MRI for Identification of Contralateral Breast Cancer at the National Consortium of Breast Centers (NCBC) Conference
Date:3/14/2011

LAS VEGAS, March 14, 2011 /PRNewswire/ -- Researchers presented data demonstrating increased specificity of Positron Emission Mammography (PEM) when compared to  MRI for the detection of breast cancer at the National Consortium of Breast Centers' 21st Annual National Interdisciplinary Breast Center Conference held March 12 – 16, 2011 in Las Vegas, Nevada.  The poster presentation, titled Pre-Surgical Detection of Malignancies in the Contralateral Breast Using Positron Emission Mammography: Comparisons with Magnetic Resonance Imaging, reveals the results of a 208 patient, single-site, IRB-approved, prospective study.

Women with newly diagnosed breast cancer have a 3-5% incidence of synchronous contralateral cancer (cancer in the opposite breast).  Because of this increased risk, accurate evaluation of the contralateral breast at the time of primary diagnosis is essential to reduce both time and cost to the patient.  Traditionally, breast MRI has been used to evaluate the breast for both ipsilateral (originally diagnosed) and contralateral disease; however, Positron Emission Mammography (PEM) is a 3-D molecular breast imaging approach that has been found to be as sensitive as breast MRI in detecting index and additional cancer in the ipsilateral breast with improved specificity.  

The study was conducted to determine whether PEM imaging would also be equally, or possibly more, sensitive than breast MRI for the identification of synchronous contralateral breast cancer. Of the 208 analyzable subjects, results showed that 71 women had contralateral breast lesions identified by either MRI or PEM.  The study confirmed that PEM and MRI identified the same cancers, both with 83% sensitivity, whereas PEM showed a trend for improved specificity with 80% vs. 63% with MRI.  PEM, unlike MRI, was not influenced by menopausal status or breast density.

"These results demonstrate that PEM has the potential to make significant contributions in pre-operative imaging evaluation of the contralateral breast in subjects with newly identified breast cancer," stated Dr. Kathy Schilling, Medical Director of Breast Imaging and Intervention for the Christine E. Lynn Women's Health and Wellness Institute at Boca Raton Regional Hospital.

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PEM scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance. For more information, call 1.858.587.3641 or visit www.naviscan.com.


'/>"/>
SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by Lieutenant Colonel, U.S. Army (Ret) Kevin Sullivan
2. Chemistry Researchers Create New Tool to Visualize Bloodstains
3. UPDATED: Elsevier Online Opinion Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level
4. CulGenex™ by Hardy Diagnostics Assists Medical Researchers!
5. Researchers Use Nanoparticles as Destructive Beacons to Zap Tumors
6. Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
7. Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer
8. Drexel Biomedical Researchers Develop Device to Predict Diabetic Wound Healing
9. Researchers at MD Anderson Show That Positron Emission Mammography (PEM) Helps Evaluate Early Response to Neoadjuvant Chemotherapy
10. SRI International Researchers Present Promising New Therapeutic for the Treatment of Multiple Myeloma
11. Researchers Pave Way for Tracking of Prostate Motion With a Single kV Imager During Arc Radiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
(Date:4/28/2016)... 28, 2016 ... Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter Softwarelösungen ... bekannt, dass neue Führungskräfte zum Team Sicherheit ... die vielfältige Erfahrungen mitbringen.  Dies wird die ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... , ... In honor of National Physical Fitness and Sports Month in May, ... fitness journey on social media. , The foot care company, which specializes in ... voucher each week during May to one winner. , “Whether the goal is to ...
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Philip Shindler, dentist in ... day treatments. In the past, many necessary dental treatments could require multiple appointments to ... anesthetic shots and extra chair time. Not only could this be inconvenient, but it ...
(Date:5/2/2016)... ... , ... MedPro Waste Disposal, LLC (MedPro) is proud to announce that it ... back service for an all-inclusive rate. MedPro Disposal President, Dan Hansen, says, “We’re really ... of the clients in the country who are looking for an alternative to their ...
(Date:5/2/2016)... ... May 02, 2016 , ... Zitter ... Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies for their achievements ... Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will ...
(Date:5/2/2016)... ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed ... Manhattan College, made the cut. The WUGC is being held in London, England this year ... gold in the men’s division, another gold in the women’s masters division, and a silver ...
Breaking Medicine News(10 mins):